$SAVA - Cassava's simufilam thoughts
SAVA stock has been unfairly beat down recently and we should step back and take a look at the bigger picture. I did drug development for Pfizer and I'm a neurologist who has treated tens of thousands of Alzheimer's patients, so I can discuss any aspect of the science. I can tell you that research papers are typically full of errors, and end up being published in big journals without anyone ever noticing. The errors don't imply fraud itself. These western blots from 15 years ago was before simufilam was even discovered. The western blots are done on a plate, which is all analog. To make it digital in the early 2000s, you had to piece it together manually in photoshop. Some old Chinese scientist may not be the best at this sort of work. The discovery of simufilam makes logical sense. Previous research done by others found excessive tau hyperphosphorylation in many neurodegenerative diseases including Alzheimer's. And they found a link between tau hyperphosp...